跳至主要内容
临床试验/EUCTR2019-004039-21-NL
EUCTR2019-004039-21-NL进行中(未招募)1 期

Efficacy of Pectoral Nerve (PECS II) Block for Breast Conserving Surgery: A Prospective Randomized Controlled Trial - CONPECSII

St Antonius Hospital0 个研究点目标入组 130 人开始时间: 2020年1月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Female gender.
  • - Unilateral breast conserving surgery.
  • - Written informed consent according to ICH/GCP and national regulations.
  • - ASA (American Society of Anesthesiologists) Class I-III .
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 130
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 130

排除标准

  • - Women < 18 year old.
  • - Bilateral surgery.
  • - Bleeding disorder or coagulopathy.
  • - Chest wall deformity or infection of injection site.
  • - Another (additional) nerve block (such as TPVB or epidural anesthesia).
  • - Oncoplastic breast conserving surgery.
  • - Autologous or implant based breast reconstruction.
  • - Known allergy for levobupivacaine or local anesthetics from the amide group.
  • - Chronic use of analgesics / opiates preoperatively (> 12 weeks).
  • - Previous breast surgery ipsi- or contralateral (except diagnostic biopsies).
  • - Not able to speak or understand the Dutch language fluently.
  • - Palliative surgery.
  • - Metastatic disease.
  • - Pregnancy or breast feeding.
  • - Psychological, neurological, familial, sociological or geographical factors that could potentially hamper compliance with the study protocol.
  • - Other concurrent solid tumor.

研究者

相似试验